Deutsche Bank Aktiengesellschaft »

Travere Therapeutics shares owned by Deutsche Bank Aktiengesellschaft

Quarter-by-quarter ownership of Travere Therapeutics (TVTX) shares owned by Deutsche Bank Aktiengesellschaft from 13F filings

Historical chart of Deutsche Bank Aktiengesellschaft investment in Travere Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Travere Therapeutics held by Deutsche Bank Aktiengesellschaft consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Travere Therapeutics by Deutsche Bank Aktiengesellschaft

Quarter filed Position value Share count Share price at filing
2023-12-31 $22M 2.4M 8.99
2023-09-30 $2.8M 309k 8.94
2023-06-30 $6.5M 425k 15.36
2023-03-31 $11M 477k 22.49
2022-12-31 $5.8M 276k 21.03
2022-09-30 $8.1M 328k 24.63
2022-06-30 $13M 545k 24.26
2022-03-31 $15M 574k 25.81
2021-12-31 $12M 398k 31.03
2021-09-30 $8.3M 341k 24.23
2021-06-30 $5.0M 342k 14.60
2021-03-31 $11M 447k 25.00
2020-12-31 $12M 444k 27.24